TheScreener - Cleopatra Hospital (CLHO) For CLEOPATRA HOSPITAL, the environment deterioration entails a downgrade to Neutral

Report

TheScreener

EUR 14.41 For Business Accounts Only

For CLEOPATRA HOSPITAL, the environment deterioration entails a downgrade to Neutral

CLEOPATRA HOSPITAL (EG), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 3 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date January 14, 2022, the closing price was EGP 5.14 and its expected value was estimated at EGP 4.88.

15/01/2022 1 EN

Underlying

Cleopatra Hospital

Cleopatra Hospital SAE is an Egypt-based hospital, which provides health and medical services, as well as the medical care of inpatients. The Company holds stakes in four hospitals in the Greater Cairo Area: Cleopatra Hospital, Cairo Specialized Hospital, Nile Badrawi Hospital and Al Shorouk Hospital, offering a full array of general and emergency healthcare services. Its service offerings include general surgery, emergency and ambulance services, cardiology, gynecology and obstetrics, oncology, orthopedics and a number of outpatient clinics, including dental, physiotherapy and primary care. The Company's facilities allow to conduct routine examinations, simple procedures and operations, and general services such as pharmacy, blood bank and diagnostic services.

See profile

EGS729J1C018 Egyptian Exchange Egypt

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Tellimer

Cleopatra Hospitals Group: Solid Performance on Volumes and Prices Growth, Despite Strong Base Effect

HEALTHY REVENUES ON VOLUMES AND PRICES GROWTH CLHO reported 1Q23 revenues of EGP777 million (+22.0% YoY, +9.1% QoQ), in line with our estimates of EGP781 million. Growth in revenues came despite a strong base in 1Q22, that included covid revenues. Annual and sequential revenue growth is driven by volumes and price increases. Number of cases served during the quarter grew by 5% YoY, along with a healthy double digit revenue growth across different services offered. Sequential growth was capped...

PREMIUM

July 10, 2023 July 10, 2023 1 EN

Tellimer

Cleopatra Hospitals Group: A relatively weak quarter on an unfavorable base effect

FLAT REVENUES ON AN UNFAVORABLE BASE EFFECT CLHO reported flat 1Q22 revenues of EGP637 million (+0.6% YoY, -1.8% QoQ), in line with our estimates of EGP640 million. Revenue performance is driven by an unfavorable solid base effect in 4Q21 and 1Q22, that were partially fueled by solid covid revenues business. Revenues were driven by a healthy 16% YoY growth in non-covid business, offsetting a 50% YoY decline in covid-related revenues. CLHO served 0.26 million cases (+10% YoY), driven by higher...

PREMIUM

May 30, 2022 May 30, 2022 1 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

For CLEOPATRA HOSPITAL, the environment deterioration entails a downgrade to Neutral

Empowering Investors

Cleopatra Hospitals Group: Solid Performance on Volumes and Prices Growth, Despite Strong Base Effect

Cleopatra Hospitals Group: A relatively weak quarter on an unfavorable base effect

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe